Postprocessing of MRIs Using FreeSurfer in Epilepsy Surgery Patients Provides an Excellent Imaging Marker of Hippocampal Sclerosis but Fails to Separate Subtypes

Objective. Histopathological examinations will diminish as minimally invasive epilepsy surgery increasingly replaces open surgery. The objective of this study was to test if visual and computer-aided quantitative analyses of presurgical high-quality 3 Tesla MRIs complying with the International League Against Epilepsy (ILAE) Neuroimaging Task Force recommendations can inform on histopathological diagnosis. Methods. Ninety-two patients from Copenhagen and Oslo University Hospitals fulfilled patient-, imaging-, and histopathological inclusion criteria: 69 patients were diagnosed with hippocampal sclerosis (HS) ILAE type 1 or 2, and 23 patients had normal appearing hippocampi or other histopathology than HS (no-HS). MRIs from 52 healthy controls (HC) were included. Image processing was performed in FreeSurfer v.6.0 with the built-in cross-sectional hippocampal subfield segmentation tool and multimodal MRI input. Volume outputs were used to calculate volume asymmetry ratios (VARs) for whole hippocampus (WH) and subfields. Results. HS patients had significantly larger WH VARs compared to no-HS patients and HC, with a sensitivity = 0.93 and specificity = 1.0 for histopathological HS diagnosis. Visual MRI assessment yielded a sensitivity = 0.90 and specificity = 0.96 for histopathological HS diagnosis. CA1 and CA4 VARs and the number of seizure-free patients were not significantly different in HS ILAE type 1 compared to type 2 patients. Significance. FreeSurfer analyses of presurgical MRIs are excellent at separating patients histopathologically diagnosed with HS from patients with other pathology or normal appearing hippocampi. Using the FreeSurfer hippocampal subfield segmentation tool did not allow for separating HS ILAE subtypes.

[1]  M. Iwasaki,et al.  Histopathological validation and clinical correlates of hippocampal subfield volumetry based on T2-weighted MRI in temporal lobe epilepsy with hippocampal sclerosis , 2021, Epilepsy Research.

[2]  C. Baumgartner,et al.  Automated volumetry of hippocampal subfields in temporal lobe epilepsy , 2021, Epilepsy Research.

[3]  R. Deichmann,et al.  Validation of automatic MRI hippocampal subfield segmentation by histopathological evaluation in patients with temporal lobe epilepsy , 2021, Seizure.

[4]  Neda Bernasconi,et al.  Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force , 2019, Epilepsia.

[5]  Roland Coras,et al.  Manual Hippocampal Subfield Segmentation Using High-Field MRI: Impact of Different Subfields in Hippocampal Volume Loss of Temporal Lobe Epilepsy Patients , 2018, Front. Neurol..

[6]  M. Baulac,et al.  New clinicopathological associations and histoprognostic markers in ILAE types of hippocampal sclerosis , 2018, Brain pathology.

[7]  R. Rocamora,et al.  Stereoelectroencephalography for Refractory Epileptic Patients Considered for Surgery: Systematic Review, Meta-Analysis, and Economic Evaluation , 2018, Neurosurgery.

[8]  Jon T. Willie,et al.  Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy , 2018, Annals of neurology.

[9]  E. Cavalheiro,et al.  Impact of hippocampal subfield histopathology in episodic memory impairment in mesial temporal lobe epilepsy and hippocampal sclerosis , 2017, Epilepsy & Behavior.

[10]  Ricardo Rego,et al.  Automated volumetry of hippocampus is useful to confirm unilateral mesial temporal sclerosis in patients with radiologically positive findings , 2017, The neuroradiology journal.

[11]  C. Elger,et al.  Laser interstitial thermotherapy (LiTT) in epilepsy surgery , 2017, Seizure.

[12]  G. Cascino,et al.  Evidence on Use of Neuroimaging for Surgical Treatment of Temporal Lobe Epilepsy: A Systematic Review. , 2016, JAMA neurology.

[13]  Neda Bernasconi,et al.  In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy , 2016, Human brain mapping.

[14]  H. Matsuda,et al.  Automated subfield volumetric analysis of hippocampus in temporal lobe epilepsy using high-resolution T2-weighed MR imaging , 2016, NeuroImage: Clinical.

[15]  Hartwig R. Siebner,et al.  The Center for Integrated Molecular Brain Imaging (Cimbi) database , 2016, NeuroImage.

[16]  Koenraad Van Leemput,et al.  A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI , 2015, NeuroImage.

[17]  Michael Buchfelder,et al.  Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy. , 2014, Brain : a journal of neurology.

[18]  M. Thom Review: Hippocampal sclerosis in epilepsy: a neuropathology review , 2014, Neuropathology and applied neurobiology.

[19]  Maria Thom,et al.  International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods , 2013, Epilepsia.

[20]  Nathalie Jette,et al.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy , 2012, Nature Reviews Neurology.

[21]  Bruce Fischl,et al.  FreeSurfer , 2012, NeuroImage.

[22]  Nobuko Kemmotsu,et al.  Temporal lobe epilepsy: quantitative MR volumetry in detection of hippocampal atrophy. , 2012, Radiology.

[23]  G. Shukla,et al.  Natural History of Temporal Lobe Epilepsy: Antecedents and Progression , 2012, Epilepsy research and treatment.

[24]  Harry B. M. Uylings,et al.  Imaging hippocampal subregions with in vivo MRI: advances and limitations , 2011, Nature Reviews Neuroscience.

[25]  Maria Thom,et al.  Reliability of patterns of hippocampal sclerosis as predictors of postsurgical outcome , 2010, Epilepsia.

[26]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[27]  I. Blümcke Neuropathology of focal epilepsies: A critical review , 2009, Epilepsy & Behavior.

[28]  E. Pauli,et al.  Clinical prediction of postoperative seizure control: structural, functional findings and disease histories , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[29]  C. Elger,et al.  A new clinico-pathological classification system for mesial temporal sclerosis , 2007, Acta Neuropathologica.

[30]  W T Blume,et al.  Proposal for a New Classification of Outcome with Respect to Epileptic Seizures Following Epilepsy Surgery , 2001, Epilepsia.

[31]  W. Van Paesschen,et al.  Quantitative hippocampal MRI and intractable temporal lobe epilepsy , 1995, Neurology.

[32]  P. Chauvel,et al.  The usefulness of stereo-electroencephalography (SEEG) in the surgical management of focal epilepsy associated with “hidden” temporal pole encephalocele: a case report and literature review , 2017, Neurosurgical Review.

[33]  S. Wiebe Burden of intractable epilepsy. , 2006, Advances in neurology.